Evidence map›Paper›PMID 34653258›Full record

ArticleInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2022

Clinical analysis of 2152 cases of abnormal uterine bleeding treated by NovaSure endometrial ablation.

Hui Xie, Yajun Wan, Shuijing Yi, Fei Zeng, Xin Sun, Yimin Yang, Songshu Xiao

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Observational
  2. Clinical analysis of 2152 cases of abnormal uterine bleeding treated by NovaSure endometrial ablation.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hui XieDepartment of Gynecology and Obstetrics, the Third Xiangya Hospital, Central South University, Changsha, China.
Yajun WanDepartment of Gynecology and Obstetrics, the Third Xiangya Hospital, Central South University, Changsha, China.
Shuijing YiDepartment of Gynecology and Obstetrics, the Third Xiangya Hospital, Central South University, Changsha, China.
Fei ZengDepartment of Gynecology and Obstetrics, the Third Xiangya Hospital, Central South University, Changsha, China.
Xin SunDepartment of Gynecology and Obstetrics, the Third Xiangya Hospital, Central South University, Changsha, China.
Yimin YangDepartment of Gynecology and Obstetrics, the Third Xiangya Hospital, Central South University, Changsha, China.
Songshu XiaoDepartment of Gynecology and Obstetrics, the Third Xiangya Hospital, Central South University, Changsha, China.
Central South University · CNThird Xiangya Hospital · CN

Funding

The Changsha Science and Technology Bureau Foundation kq1701085The Changsha Science and Technology Bureau Foundation kq1701087The Graduate research project of Central South University 2018-75The project of degree and postgraduate education and teaching reform in Hunan Province JG2018A003The Project of Hunan Provincial Natural Science Foundation 2018JJ3782
6 · The paper itself

Abstract

objectiveTo evaluate the efficiency, postoperative hysterectomy rate, and influencing factors for therapeutic effect of the NovaSure endometrial ablation procedure in abnormal uterine bleeding (AUB).

methodsWe conducted a retrospective cohort study of 2152 patients from the Department of Gynecology at the Third Xiangya Hospital, CSU from October 2010 to December 2018.

resultsFrom the first year to the eighth year after operation, annual effective rate was above 95.24%, and the differences were not statistically significant. There are statistically significant differences between the effective and ineffective groups with regard to age, intrauterine polyps, total length of the uterus, systemic coagulation disorder, and preoperative hemoglobin. A multivariate logistic regression analysis showed that the risk factors associated with systemic coagulation disorders (P = 0.027) and high total uterine length (P = 0.003) affected NovaSure efficacy in the treatment of AUB. By December 2019, the postoperative hysterectomy rate was 1.86% (40/2152) and the complication rate was 1.67% (36/2152).

conclusionNovaSure is a reliable treatment for AUB and serious medical complications because of its simple operation, low amount of bleeding, quick postoperative recovery, and safe and effective short-term and long-term efficacy. However, it should be carefully selected for patients with a total uterus length exceeding 10 cm.

Indexed as

Endometrial Ablation TechniquesUterine NeoplasmsFemaleHumansRetrospective StudiesTreatment OutcomeUterine HemorrhageUterusabnormal uterine bleedingendometrial ablationNovaSure endometrial ablation

Identifiers

PMID34653258
PMCPMC9540028
OpenAlexW3206766906

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.